Lamis Naddaf

Lamis Naddaf

Auto-generated profile, based on publicly available information

Lamis Naddaf

Department of Biochemistry and Molecular Medicine, Keck School of Medicine University of Southern California Los Angeles California USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2022 in Science Advances
Verified
Journal Article
Open access
NNNishanth Ulhas Nair
Nishanth Ulhas Nair
KCKuoyuan Cheng
Kuoyuan Cheng
LNLamis Naddaf
Lamis Naddaf
ESElad Sharon
Elad Sharon
LPLipika R. Pal
Lipika R. Pal
EREytan Ruppin
Eytan Ruppin
Cancer is a predominant disease across animals. We applied a comparative genomics approach to systematically characterize genes whose conservation levels correlate positively (PC) or negatively (NC) with cancer resistance estimates across 193 vertebrates. Pathway analysis reveals that NC genes are enriched for metabolic functions and PC genes in cell cycle regulation, DNA repair, and immune response, pointing to their corresponding roles in mediating cancer risk. We find that PC genes are less tolerant to loss-of-function (LoF) mutations, are enriched in cancer driver genes, and are associated with germline mutations that increase human cancer risk. Their relevance to cancer risk is further supported via the analysis of mouse functional genomics and cancer mortality of zoo mammals’ data. In sum, our study describes a cross-species genomic analysis pointing to candidate genes that may mediate human cancer risk.

28 January 2025 in Aging and Cancer
Verified
Journal Article
Open access
LNLamis Naddaf
Lamis Naddaf
SLSheng Li
Sheng Li
Background: Cancer's inherent ability to evolve presents significant challenges for its categorization and treatment. Cancer evolution is driven by genetic, epigenetic, and phenotypic diversity influenced by microenvironment changes. Aging plays a crucial role by altering the microenvironment and inducing substantial genetic and epigenetic heterogeneity within an individual's somatic cells even before cancer initiation.Objectives: This review highlights the clinical significance of epigenetic mechanisms in cancer evolution, focusing on hematopoietic and solid tumors. The review aims to explore opportunities for integrating evolutionary principles and data science into cancer research.Methods: The review synthesizes recent advancements in omics technologies, single‐cell sequencing, and genetic barcoding to elucidate epigenetic mechanisms and aging's role in cancer evolution.Results: Epigenetic mechanisms' high plasticity generates heritable phenotypic diversity, driving malignant evolution toward poor prognosis. Advances in single‐cell sequencing and genetic barcoding enable the precise detection and tracking of biomarkers, allowing early, personalized interventions. Incorporating data science into cancer research has the potential to map, predict, and prevent cancer evolution effectively.Conclusion: Understanding cancer evolution through novel technologies and data analysis offers a proactive approach to cancer prevention and treatment. By predicting key evolutionary events and leveraging personalized strategies, patient outcomes can be improved, and healthcare burdens reduced, marking a transformative shift in oncology.